UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis

BMJ case reports, 2019-02, Vol.12 (2), p.e227916

2019

Volltextzugriff (PDF)

Transmission of monkeypox virus through sexual contact – A novel route of infection

The Journal of infection, 2022-09, Vol.85 (3), p.334-363

2022

Volltextzugriff (PDF)

The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort

International journal of infectious diseases, 2023-01, Vol.126, p.48-53

2023

Volltextzugriff (PDF)

Parvovirus B19 induced acute severe anaemia in a well-controlled HIV-positive individual

Clinical infection in practice, 2024-01, Vol.21, p.100334, Article 100334

2024

Volltextzugriff (PDF)

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report

AIDS (London), 2015-05, Vol.29 (8), p.982-985

2015

Volltextzugriff (PDF)

Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial

HIV research & clinical practice, 2021-12, Vol.22 (6), p.151-159

2021

Volltextzugriff (PDF)

Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis

The Lancet infectious diseases, 2022-09, Vol.22 (9), p.1321-1328

2022

Volltextzugriff (PDF)

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

Journal of antimicrobial chemotherapy, 2021-09, Vol.76 (9), p.2380-2393

2021

Volltextzugriff (PDF)

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

Journal of antimicrobial chemotherapy, 2023-09, Vol.78 (9), p.2361-2365

2023

Volltextzugriff (PDF)

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease

Journal of antimicrobial chemotherapy, 2020-11, Vol.75 (11), p.3334-3343

2020

Volltextzugriff (PDF)

Community transmission of monkeypox in the United Kingdom, April to May 2022

Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-06, Vol.27 (22), p.1

2022

Volltextzugriff (PDF)

Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy

Journal of antimicrobial chemotherapy, 2014-06, Vol.69 (6), p.1642-1647

2014

Volltextzugriff (PDF)

Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial

Clinical infectious diseases, 2015-04, Vol.60 (7), p.1026-1032

2015

Volltextzugriff (PDF)

Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection

The Lancet infectious diseases, 2023-06, Vol.23 (6), p.e218-e226

2023

Volltextzugriff (PDF)

Cognitive Impairment in a Clinical Setting

Journal of acquired immune deficiency syndromes (1999), 2018-01, Vol.77 (1), p.e10-e13

2018

Volltextzugriff (PDF)

Changes in functional connectivity in people with HIV switching antiretroviral therapy

Journal of neurovirology, 2020-10, Vol.26 (5), p.754-763

2020

Volltextzugriff (PDF)

Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1348-1353

2013

Volltextzugriff (PDF)

A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease

British journal of radiology, 2016-01, Vol.89 (1060), p.20150979-20150979

2016

Volltextzugriff (PDF)

Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals

AIDS (London), 2018-05, Vol.32 (8), p.1007-1015

2018

Volltextzugriff (PDF)

Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naïve HIV-Positive Individuals; A Randomised Controlled Study

AIDS (London), 2018-02

2018

Volltextzugriff (PDF)

HIV-1 CNS in vitro infectivity models based on clinical CSF samples

Journal of antimicrobial chemotherapy, 2016-01, Vol.71 (1), p.235-243

2016

Volltextzugriff (PDF)

A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1812-1815

2015

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Infectious Diseases
(24)
Humans
(22)
Male
(18)
Hiv Infections - Drug Therapy
(15)
Adult
(12)
Hiv
(12)
Middle Aged
(12)
Microbiology
(11)
Human Immunodeficiency Virus
(9)
Immunology
(9)
Pharmacology & Pharmacy
(8)
Female
(7)
Hiv Infections - Complications
(7)
Antiretroviral Drugs
(6)
Homosexuality, Male
(5)
Virology
(5)
Antiretroviral Therapy, Highly Active
(4)
Cd4 Lymphocyte Count
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis

Transmission of monkeypox virus through sexual contact – A novel route of infection

The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort

Parvovirus B19 induced acute severe anaemia in a well-controlled HIV-positive individual

Apparent spontaneous clearance of chronic hepatitis C virus infection in a HIV co-infected patient with decompensated cirrhosis: a case report

Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial

Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease

Community transmission of monkeypox in the United Kingdom, April to May 2022

Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy

Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial

Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection

Cognitive Impairment in a Clinical Setting

Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial

Changes in functional connectivity in people with HIV switching antiretroviral therapy

Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects

A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease

Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals

Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naïve HIV-Positive Individuals; A Randomised Controlled Study

HIV-1 CNS in vitro infectivity models based on clinical CSF samples

A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers

Suchergebnisse filtern